AstraZeneca forecasts 2022 growth even as COVID revenue wanes

While sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.

Latest articles

Related articles